Search Results - "Tholomier, Côme"

Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer by Rompré-Brodeur, Alexis, Marcq, Gautier, Tholomier, Côme, Fugaru, Ioana, Loutochin, Oleg, Anidjar, Maurice, Bladou, Franck

“…PURPOSEPartial gland ablation (PGA) using high-intensity focused ultrasound (HIFU) is currently under investigation for clinically significant prostate cancer…”
Get full text

The current status of gene therapy in bladder cancer by Tholomier, Côme, Martini, Alberto, Mokkapati, Sharada, Dinney, Colin P.

“…Gene therapy aims to alter the biological properties of cells through the therapeutic delivery of nucleotides to treat a disease. Although originally developed…”
Get full text

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer by Tholomier, Côme, Souhami, Luis, Kassouf, Wassim

“…Bladder-sparing protocols (BSP) have been gaining widespread popularity as an attractive alternative to radical cystectomy (RC) for muscle-invasive bladder…”
Get full text

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval by Martini, Alberto, Tholomier, Côme, Mokkapati, Sharada, Dinney, Colin P. N.

“…Bladder cancer is a prevalent malignancy with limited therapeutic options, particularly for patients who are unresponsive to Bacillus Calmette-Guérin (BCG)…”
Get full text

Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review by Tholomier, Côme, Wang, Yifan, Aleynikova, Olga, Vanounou, Tsafrir, Pelletier, Jean-Sebastien

“…Biliary mucinous cystic neoplasms are rare cystic lesions of the liver which carry pre-malignant potential. Given the scarcity of reports in the literature,…”
Get full text

Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety by Law, Kyle W., Tholomier, Côme, Nguyen, David-Dan, Sadri, Iman, Couture, Félix, Zakaria, Ahmed S., Bouhadana, David, Bruyère, Franck, Cash, Hannes, Reimann, Maximilian, Cindolo, Luca, Ferrari, Giovanni, Vasquez-Lastra, Carlos, Borelli-Bovo, Tiago J., Becher, Edgardo F., Misrai, Vincent, Elterman, Dean, Bhojani, Naeem, Zorn, Kevin C.

“…Introduction Greenlight photo-selective vaporization of the prostate (GL-PVP) has gained international acceptance as a safe and effective alternative procedure…”
Get full text

Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center by Zakaria, Ahmed S., Couture, Félix, Nguyen, David-Dan, Tholomier, Côme, Shahine, Hanna, Stolzenbach, Franziska, Meskawi, Malek, Karakiewicz, Pierre I., El-Hakim, Assaad, Zorn, Kevin C.

“…Purpose Most Canadian hospitals face significant reductions in operating room access during the summer. We sought to assess the impact of longer wait times on…”
Get full text

Prostate cancer biochemical recurrence after salvage radiotherapy: first look into risk stratification and prognosis by Couture, Félix, Tholomier, Côme, Zorn, Kevin C.

Get full text

Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence? by Zakaria, Ahmed S., Schwartz, Russell N., Hodhod, Amr, Couture, Félix, Tholomier, Côme, Shahine, Hanna, Negrean, Cristina, Nguyen, David-Dan, Zanaty, Marc, Stolzenbach, Franziska, Karakiewicz, Pierre I., El-Hakim, Assaad, Zorn, Kevin C.

“…Purpose The aim of the study is to evaluate the impact of having a nadir and persistently detectable ultrasensitive prostate-specific antigen (uPSA) between…”
Get full text

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model by Steinmetz, Alexis R., Pierce, Morgan, Martini, Alberto, Tholomier, Come, Manyam, Ganiraju, Chen, Yan, Sood, Akshay, Duplisea, Jonathan J., Johnson, Burles A., Czerniak, Bogdan A., Lee, Byron H., Jagannath, Chinnaswamy, Yla-Herttuala, Seppo, Parker, Nigel R., McConkey, David J., Dinney, Colin P., Mokkapati, Sharada

“…Nadofaragene firadenovec (Ad-IFNα/Syn3) is now approved for BCG-unresponsive bladder cancer (BLCA). IFNα is a pleiotropic cytokine that causes direct tumor…”
Get full text

MP65-06 NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES by Steinmetz, Alexis, Tholomier, Côme, Martini, Alberto, McConkey, David, Mokkapati, Sharada, Dinney, Colin

Get full text

MP65-05 SINGLE-CELL RNA SEQUENCING IDENTIFIES CHANGES IN TUMOR MICROENVIRONMENT INDUCED BY INTERFERON α GENE THERAPY IN MURINE BLADDER CANCER MODEL by Mokkapati, Sharada, Martini, Alberto, Tholomier, Côme, Manyam, Ganiraju, Steinmetz, Alexis, Chen, Yan, Dinney, Colin

Get full text

Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate by Lichy, Isabel, Law, Kyle, Tholomier, Côme, Nguyen, David-Dan, Sadri, Iman, Bouhadana, David, Couture, Félix, Zakaria, Ahmed S., Bhojani, Naeem, Zorn, Kevin C., Bruyère, Franck, Cindolo, Luca, Ferrari, Giovanni, Vasquez-Lastra, Carlos, Borelli-Bovo, Tiago J., Becher, Edgardo F., Misrai, Vincent, Elterman, Dean, Reimann, Maximilian, Cash, Hannes

“…Purpose To evaluate changes in global perioperative data of GreenLight-XPS 180-Watt photo-selective vaporization of the prostate (GL-XPS) of the Global…”
Get full text

PD51-12 COST-EFFECTIVENESS OF IMMUNOTHERAPIES IN METASTATIC BLADDER CANCER: A CANADIAN HEALTHCARE PERSPECTIVE by Tholomier, Côme, Nazha, Sara, Dragomir, Alice, Kassouf, Wassim

Get full text

MP65-12 FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER by Tholomier, Côme, Rudzsinki, Jan K., Steinmetz, Alexis, Martini, Alberto, Sood, Akshay, McConkey, David J., Dinney, Colin P. N.

Get full text

Reply by Authors by Rompré-Brodeur, Alexis, Marcq, Gautier, Tholomier, Côme, Fugaru, Ioana, Loutochin, Oleg, Anidjar, Maurice, Bladou, Franck

Get full text

NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES by Steinmetz, Alexis, Tholomier, Côme, Martini, Alberto, Mokkapati, Sharada, Dinney, Colin PN, McConkey, David

“…Interferon alpha (IFNα) gene therapy with Nadofaragene firadenovec is emerging as a promising therapeutic option for patients with BCG-unresponsive non-muscle…”
Get full text

Safety, Perioperative, and Early Functional Outcomes of Vapor Incision Technique Using the GreenLight XPS 180 W System: Direct Comparison with Photoselective Vaporization of the Prostate by Azizi, Mounsif, Tholomier, Côme, Meskawi, Malek, Hueber, Pierre-Alain, Valdivieso, Roger F, Alenizi, Abdullah M, Rajih, Emad, Zanaty, Marc, Hai, Mahmood A, Gonzalez, Ricardo R, Eure, Gregg R, Kriteman, Lewis S, Misrai, Vincent, Zorn, Kevin C

“…To compare perioperative parameters, safety, and short-term functional outcomes between GreenLight 180 W-XPS photoselective vaporization of the prostate (PVP)…”
Get more information

Predictors of deviation in neurovascular bundle preservation during robotic prostatectomy by Couture, Félix, Polesello, Stefano, Tholomier, Côme, Bondarenko, Helen Davis, Karakiewicz, Pierre I, Nazzani, Sebastiano, Preisser, Felix, El-Hakim, Assaad, Zorn, Kevin C

“…Neurovascular bundle (NVB) preservation during robot-assisted radical prostatectomy (RARP) directly affects patient functional outcomes. Despite careful…”
Get more information

180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes by Zhou, Joris, Tholomier, Côme, Zanaty, Marc, Hueber, Pierre-Alain, Valdivieso, Roger, Karakewicz, Pierre, Liberman, Daniel, Misrai, Vincent, Zorn, Kevin C

“…This study aims at analyzing the impact of reaching current markers of proficiency on intra and postoperative clinical outcomes of laser vaporization with 180W…”
Get more information